Hundreds of leaders from cross-sector arenas in government, academia, the biotechnology and pharmaceutical industry, and patient advocacy organizations gathered over the past two days at Critical Path Institute’s Creating Consensus Science: Tools and Tactics for Next-Gen Drug Development conference to articulate a common commitment to the future of global collaborative efforts that develop innovative tools to accelerate medical product development.
